What is the prevalence of Amyloidosis?
How many people does Amyloidosis affect? Does it have the same prevalence in men and women? And in the different countries?
Amyloidosis is a rare group of diseases characterized by the abnormal accumulation of amyloid protein in various organs and tissues. The prevalence of amyloidosis varies depending on the specific type and geographical location. Systemic amyloidosis, the most common form, affects approximately 1 in 100,000 individuals worldwide. However, localized forms of amyloidosis, such as Alzheimer's disease, can have a higher prevalence. Early diagnosis and treatment are crucial for managing this complex condition.
Amyloidosis is a rare group of diseases characterized by the abnormal accumulation of amyloid proteins in various organs and tissues throughout the body. The prevalence of amyloidosis varies depending on the specific type and geographical location.
Systemic amyloidosis, the most common form, affects multiple organs and has an estimated prevalence of 1 to 12 cases per million people worldwide. Within systemic amyloidosis, primary amyloidosis (AL) is the most prevalent subtype, accounting for approximately 85% of cases. AL amyloidosis has an incidence of 8 to 12 cases per million people per year.
Other forms of amyloidosis, such as hereditary (ATTR) and secondary (AA) amyloidosis, are less common. ATTR amyloidosis has a prevalence of 5 to 50 cases per million people, while AA amyloidosis is associated with chronic inflammatory conditions and its prevalence varies depending on the underlying disease.
It is important to note that due to the rarity and complexity of amyloidosis, accurate prevalence data can be challenging to obtain. However, ongoing research and improved diagnostic techniques are helping to enhance our understanding of this condition.
Posted Jul 11, 2019 by ESPERARE
Posted Jun 3, 2017 by Nancy 2000
Posted Jul 19, 2017 by Phyllis 2000
